Genenta Science S.p.A. (GNTA) vs Metagenomi Therapeutics (MGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Metagenomi Therapeutics (MGX) has outperformed Genenta Science S.p.A. (GNTA) over the past year, losing 68.9% versus a loss of 78.4%. Metagenomi Therapeutics is the larger company by market cap ($37.5 million vs $34.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GNTA | MGX |
|---|---|---|
| Share price | $0.7101 | $0.9932 |
| Market cap | $34.24M | $37.52M |
| 1-day change | -5.95% | +0.86% |
| YTD return | -52.34% | -38.69% |
| 1-year return | -78.35% | -68.87% |
| EPS (TTM) | $-0.37 | $-2.49 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.00 | $3.95 |
| 52-week low | $0.55 | $0.96 |
| Distance from 52-week high | -92.90% | -74.86% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +604.79% |
| Average volume | 61.46K | 158.27K |
| Shares outstanding | 48.22M | 37.78M |
| Employees | 9 | 113 |
| Sector | Industrials | Healthcare |
| Industry | Conglomerates | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Genenta Science S.p.A. in Industrials and Metagenomi Therapeutics in Healthcare.
About Genenta Science S.p.A.
GNTA stock →Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors.
Industrials · Conglomerates · 9 employees
About Metagenomi Therapeutics
MGX stock →Metagenomi Therapeutics, Inc. an in vivo genome editing company, develops curative genetic medicines in the United States.
Healthcare · Biotechnology · 113 employees
GNTA vs MGX FAQ
Which is bigger, Genenta Science S.p.A. or Metagenomi Therapeutics?
Metagenomi Therapeutics (MGX) is larger, with a market capitalization of $37.52M compared with $34.24M for Genenta Science S.p.A. (GNTA).
Which stock has performed better over the past year, GNTA or MGX?
MGX returned -68.87% over the past 12 months, compared with -78.35% for GNTA (price return, excluding dividends). Past performance does not predict future results.
Are Genenta Science S.p.A. and Metagenomi Therapeutics in the same industry?
No. Genenta Science S.p.A. is in the Industrials sector, while Metagenomi Therapeutics is in Healthcare.